NCT01480271
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Zuidlaren, Netherlands
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,753 public trials
646 recruiting studies
Hypersensitivity trial results
NCT02835300
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 3-C Institute for Social Development, dba 3C Institute Durham, North Carolina, United States
NCT01476059
- Conditions
- Asthma, Behavior, Bronchial Diseases, +11 more
- Locations
-
Not specified
NCT01854047
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Investigational Site Number 840050 Fullerton, California, United States
- Investigational Site Number 840041 Huntington Beach, California, United States
- Investigational Site Number 840019 Los Angeles, California, United States
- Investigational Site Number 840029 Los Angeles, California, United States
NCT00549744
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Wellington, New Zealand
- GSK Investigational Site George, Eastern Cape, South Africa
- GSK Investigational Site Bloemfontein, South Africa
Completed
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT02975843
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +12 more
- Locations
-
Not specified
NCT01000597
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
NCT02512900
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Research Site Kielce, Poland
- Research Site Lodz, Poland
- Research Site Wroclaw, Poland
- Research Site Wroclaw, Poland
Completed
Japanese Phase 1 Study of Mepolizumab
NCT01471327
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia